Charles River Lbrtrs ntrntl Inc
General ticker "CRL" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $10.0B
Charles River Lbrtrs ntrntl Inc does not follow the US Stock Market performance with the rate: -6.5%.
Estimated limits based on current volatility of 2.1%: low 181.42$, high 189.24$
Factors to consider:
- Company included in S&P500 list
- US accounted for 56.8% of revenue in the fiscal year ended 2023-12-30
- Current price 10.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-30 to 2025-12-29
- 2023-12-30 to 2024-12-29 estimated range: [207.53$, 295.22$]
- 2024-12-29 to 2025-12-29 estimated range: [239.53$, 332.52$]
Financial Metrics affecting the CRL estimates:
- Positive: Non-GAAP EPS, $ of 10.65 > 2.29
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Investing cash flow per share, $ of -10.99 <= -3.48
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: 9.05 < Operating profit margin, % of 14.95
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 5.54
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Inventory ratio change, % of 3.46 > 1.08
Short-term CRL quotes
Long-term CRL plot with estimates
Financial data
| YTD | 2021-12-25 | 2022-12-31 | 2023-12-30 |
|---|---|---|---|
| Operating Revenue | $3,540.16MM | $3,976.06MM | $4,129.41MM |
| Operating Expenses | $2,950.30MM | $3,325.09MM | $3,512.15MM |
| Operating Income | $589.86MM | $650.98MM | $617.26MM |
| Non-Operating Income | $-109.15MM | $-27.99MM | $-35.98MM |
| Interest Expense | $73.91MM | $59.29MM | $136.71MM |
| Income(Loss) | $480.71MM | $622.99MM | $581.28MM |
| Taxes | $81.87MM | $130.38MM | $100.91MM |
| Profit(Loss) | $398.84MM | $492.61MM | $480.37MM |
| Stockholders Equity | $2,534.82MM | $2,976.29MM | $3,596.88MM |
| Inventory | $199.15MM | $255.81MM | $380.26MM |
| Assets | $7,024.29MM | $7,602.77MM | $8,195.00MM |
| Operating Cash Flow | $760.80MM | $619.64MM | $683.90MM |
| Capital expenditure | $228.77MM | $324.73MM | $318.53MM |
| Investing Cash Flow | $-1,437.93MM | $-607.92MM | $-563.15MM |
| Financing Cash Flow | $672.60MM | $-42.40MM | $-85.52MM |
| Earnings Per Share* | $7.77 | $9.57 | $9.27 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.